Aspire Biopharma Warrant (ASBPW)

• Market cap: $410K
• 1 day: -29.17%
• 5 days: 12.58%
• 1 month: -10.53%
• 3 months: -8.11%
• 6 months: -38.18%
• Year to date: -8.6%
• 1 year: -45.34%
• 5 years: -95.14%
• 10 years: -95.14%
• Sector: Healthcare
• Industry: Biotechnology

About: Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.